Cargando…

A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C

BACKGROUND: Von Hippel-Lindau (VHL) disease is an autosomal dominant inherited disease. It is relatively recent that type 2C was identified as a separate group solely presenting with pheochromocytomas. As an illustration, an interesting case is presented of a pregnant woman with refractory hypertens...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreinemakers, Jennifer MJ, Zonnenberg, Bernard A, Höppener, Jo WM, Hes, Frederik J, Rinkes, Inne HM Borel, Lips, Cornelis JM
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169240/
https://www.ncbi.nlm.nih.gov/pubmed/17922902
http://dx.doi.org/10.1186/1477-7819-5-112
_version_ 1782144855360667648
author Schreinemakers, Jennifer MJ
Zonnenberg, Bernard A
Höppener, Jo WM
Hes, Frederik J
Rinkes, Inne HM Borel
Lips, Cornelis JM
author_facet Schreinemakers, Jennifer MJ
Zonnenberg, Bernard A
Höppener, Jo WM
Hes, Frederik J
Rinkes, Inne HM Borel
Lips, Cornelis JM
author_sort Schreinemakers, Jennifer MJ
collection PubMed
description BACKGROUND: Von Hippel-Lindau (VHL) disease is an autosomal dominant inherited disease. It is relatively recent that type 2C was identified as a separate group solely presenting with pheochromocytomas. As an illustration, an interesting case is presented of a pregnant woman with refractory hypertension. It proved to be the first manifestation of bilateral pheochromocytomas. The family history may indicate the diagnosis, but only identification of a germ line mutation in the DNA of a patient will confirm carriership. CASE PRESENTATION: A 27 year pregnant patient with intra uterine growth retardation presented with hypertension and pre-eclampsia. Magnetic resonance imaging revealed bilateral adrenal pheochromocytoma. She underwent laparoscopic adrenelectomy and a missense mutation (Gly93Ser) in exon 1 of the VHL gene on chromosome 3 (p25 – p26) was shown in the patient, her father and her daughter confirming the diagnosis of VHL. CONCLUSION: In almost all VHL families molecular genetic analysis of DNA will demonstrate an inherited mutation. Because of the involvement in several organs, periodic clinical evaluation should take place in a well coordinated, multidisciplinary setting. VHL disease can be classified into several subtypes. VHL type 2C patients present with pheochromocytomas without evidence of haemangioblastomas in the central nervous system and/or retina and a low risk of renal cell carcinoma. Therefore, in such families, periodic clinical screening can be focussed on pheochromocytomas.
format Text
id pubmed-2169240
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-21692402007-12-29 A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C Schreinemakers, Jennifer MJ Zonnenberg, Bernard A Höppener, Jo WM Hes, Frederik J Rinkes, Inne HM Borel Lips, Cornelis JM World J Surg Oncol Case Report BACKGROUND: Von Hippel-Lindau (VHL) disease is an autosomal dominant inherited disease. It is relatively recent that type 2C was identified as a separate group solely presenting with pheochromocytomas. As an illustration, an interesting case is presented of a pregnant woman with refractory hypertension. It proved to be the first manifestation of bilateral pheochromocytomas. The family history may indicate the diagnosis, but only identification of a germ line mutation in the DNA of a patient will confirm carriership. CASE PRESENTATION: A 27 year pregnant patient with intra uterine growth retardation presented with hypertension and pre-eclampsia. Magnetic resonance imaging revealed bilateral adrenal pheochromocytoma. She underwent laparoscopic adrenelectomy and a missense mutation (Gly93Ser) in exon 1 of the VHL gene on chromosome 3 (p25 – p26) was shown in the patient, her father and her daughter confirming the diagnosis of VHL. CONCLUSION: In almost all VHL families molecular genetic analysis of DNA will demonstrate an inherited mutation. Because of the involvement in several organs, periodic clinical evaluation should take place in a well coordinated, multidisciplinary setting. VHL disease can be classified into several subtypes. VHL type 2C patients present with pheochromocytomas without evidence of haemangioblastomas in the central nervous system and/or retina and a low risk of renal cell carcinoma. Therefore, in such families, periodic clinical screening can be focussed on pheochromocytomas. BioMed Central 2007-10-08 /pmc/articles/PMC2169240/ /pubmed/17922902 http://dx.doi.org/10.1186/1477-7819-5-112 Text en Copyright © 2007 Schreinemakers et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Schreinemakers, Jennifer MJ
Zonnenberg, Bernard A
Höppener, Jo WM
Hes, Frederik J
Rinkes, Inne HM Borel
Lips, Cornelis JM
A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C
title A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C
title_full A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C
title_fullStr A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C
title_full_unstemmed A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C
title_short A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C
title_sort patient with bilateral pheochromocytoma as part of a von hippel-lindau (vhl) syndrome type 2c
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169240/
https://www.ncbi.nlm.nih.gov/pubmed/17922902
http://dx.doi.org/10.1186/1477-7819-5-112
work_keys_str_mv AT schreinemakersjennifermj apatientwithbilateralpheochromocytomaaspartofavonhippellindauvhlsyndrometype2c
AT zonnenbergbernarda apatientwithbilateralpheochromocytomaaspartofavonhippellindauvhlsyndrometype2c
AT hoppenerjowm apatientwithbilateralpheochromocytomaaspartofavonhippellindauvhlsyndrometype2c
AT hesfrederikj apatientwithbilateralpheochromocytomaaspartofavonhippellindauvhlsyndrometype2c
AT rinkesinnehmborel apatientwithbilateralpheochromocytomaaspartofavonhippellindauvhlsyndrometype2c
AT lipscornelisjm apatientwithbilateralpheochromocytomaaspartofavonhippellindauvhlsyndrometype2c
AT schreinemakersjennifermj patientwithbilateralpheochromocytomaaspartofavonhippellindauvhlsyndrometype2c
AT zonnenbergbernarda patientwithbilateralpheochromocytomaaspartofavonhippellindauvhlsyndrometype2c
AT hoppenerjowm patientwithbilateralpheochromocytomaaspartofavonhippellindauvhlsyndrometype2c
AT hesfrederikj patientwithbilateralpheochromocytomaaspartofavonhippellindauvhlsyndrometype2c
AT rinkesinnehmborel patientwithbilateralpheochromocytomaaspartofavonhippellindauvhlsyndrometype2c
AT lipscornelisjm patientwithbilateralpheochromocytomaaspartofavonhippellindauvhlsyndrometype2c